Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yubo He

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Signal Transduction and Targeted Therapy|November 13, 2025
Oligomeric cystatin C supports the immunosuppressive activity of myeloid cells through interaction with inhibitory receptorsChengcheng Zhang, Yubo He, Xiaoye Liu, et al.
Nature Immunology|July 24, 2025
Secretogranin 2 binds LILRB4 resulting in immunosuppressionXing Yang, Ryan Huang, Meng Fang, et al.
Cancer Immunology Research|March 27, 2025
Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor DevelopmentYubo He, Chengcheng Zhang, Lingxiao Tan, et al.
Cancer Immunology Research|December 19, 2023
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor DevelopmentRyan Huang, Xiaoye Liu, Jaehyup Kim, et al.
Frontiers in Immunology|October 10, 2022
Blocking LAIR1 signaling in immune cells inhibits tumor developmentJingjing Xie, Xun Gui, Mi Deng, et al.
Science Immunology|April 3, 2026
Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancerXiaoye Liu, Ryan Huang, Zhiqiang Ku, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Signal Transduction and Targeted Therapy|November 13, 2025
Oligomeric cystatin C supports the immunosuppressive activity of myeloid cells through interaction with inhibitory receptorsChengcheng Zhang, Yubo He, Xiaoye Liu, et al.
Nature Immunology|July 24, 2025
Secretogranin 2 binds LILRB4 resulting in immunosuppressionXing Yang, Ryan Huang, Meng Fang, et al.
Cancer Immunology Research|March 27, 2025
Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor DevelopmentYubo He, Chengcheng Zhang, Lingxiao Tan, et al.
Cancer Immunology Research|December 19, 2023
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor DevelopmentRyan Huang, Xiaoye Liu, Jaehyup Kim, et al.
Frontiers in Immunology|October 10, 2022
Blocking LAIR1 signaling in immune cells inhibits tumor developmentJingjing Xie, Xun Gui, Mi Deng, et al.
Science Immunology|April 3, 2026
Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancerXiaoye Liu, Ryan Huang, Zhiqiang Ku, et al.
Pageof 3